Cell Impact AB (publ) (STO:CI)
Sweden · Delayed Price · Currency is SEK 0.0178
-0.0002 (-1.11%)
Aug 4, 2025, 10:51 AM CET
bluebird bio Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 33.46 | 37.33 | 47.26 | 77.42 | 71.35 | 29.31 | Upgrade |
Other Revenue | 0.36 | 0.6 | 0.4 | 0.9 | 10.45 | - | Upgrade |
| 33.81 | 37.92 | 47.66 | 78.32 | 81.8 | 29.31 | Upgrade | |
Revenue Growth (YoY) | 0.31% | -20.43% | -39.14% | -4.26% | 179.09% | 145.00% | Upgrade |
Cost of Revenue | 32.45 | 31.91 | 21.81 | 39.87 | 46.92 | 10.17 | Upgrade |
Gross Profit | 1.37 | 6.01 | 25.85 | 38.45 | 34.88 | 19.14 | Upgrade |
Selling, General & Admin | 56.07 | 62.27 | 120.04 | 124 | 102.68 | 55.27 | Upgrade |
Other Operating Expenses | 11.51 | 11.5 | 1.64 | 1.53 | 0.05 | 0.2 | Upgrade |
Operating Expenses | 99.12 | 105.03 | 145.34 | 141.91 | 112.92 | 62.19 | Upgrade |
Operating Income | -97.76 | -99.02 | -119.49 | -103.47 | -78.04 | -43.06 | Upgrade |
Interest Expense | -2.59 | -2.56 | -3.05 | -1.54 | -1.69 | -1.23 | Upgrade |
Interest & Investment Income | 1.47 | 1.47 | 1.18 | 0.86 | - | 0.03 | Upgrade |
Currency Exchange Gain (Loss) | -0.23 | -0.23 | - | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | - | -0 | -0 | -0 | -0 | - | Upgrade |
Pretax Income | -99.11 | -100.35 | -121.36 | -104.15 | -79.73 | -44.26 | Upgrade |
Income Tax Expense | -0.58 | 0.09 | 0.04 | 0.07 | 0.12 | - | Upgrade |
Net Income | -98.53 | -100.43 | -121.4 | -104.22 | -79.85 | -44.26 | Upgrade |
Net Income to Common | -98.53 | -100.43 | -121.4 | -104.22 | -79.85 | -44.26 | Upgrade |
Shares Outstanding (Basic) | 644 | 618 | 110 | 76 | 59 | 50 | Upgrade |
Shares Outstanding (Diluted) | 644 | 618 | 110 | 76 | 59 | 50 | Upgrade |
Shares Change (YoY) | 170.13% | 463.84% | 44.78% | 27.89% | 17.66% | 50.40% | Upgrade |
EPS (Basic) | -0.15 | -0.16 | -1.11 | -1.38 | -1.35 | -0.88 | Upgrade |
EPS (Diluted) | -0.15 | -0.16 | -1.11 | -1.38 | -1.35 | -0.88 | Upgrade |
Free Cash Flow | -42.5 | -74.64 | -156.29 | -168.37 | -139.05 | -69.64 | Upgrade |
Free Cash Flow Per Share | -0.07 | -0.12 | -1.43 | -2.22 | -2.35 | -1.38 | Upgrade |
Gross Margin | 4.04% | 15.86% | 54.24% | 49.09% | 42.64% | 65.29% | Upgrade |
Operating Margin | -289.12% | -261.11% | -250.70% | -132.11% | -95.40% | -146.90% | Upgrade |
Profit Margin | -291.41% | -264.83% | -254.71% | -133.07% | -97.62% | -151.00% | Upgrade |
Free Cash Flow Margin | -125.68% | -196.81% | -327.92% | -214.98% | -169.99% | -237.60% | Upgrade |
EBITDA | -78.62 | -80.16 | -106.32 | -92.29 | -72.3 | -38.93 | Upgrade |
EBITDA Margin | -232.51% | -211.37% | -223.07% | -117.84% | -88.39% | -132.83% | Upgrade |
D&A For EBITDA | 19.14 | 18.86 | 13.17 | 11.18 | 5.74 | 4.12 | Upgrade |
EBIT | -97.76 | -99.02 | -119.49 | -103.47 | -78.04 | -43.06 | Upgrade |
EBIT Margin | -289.12% | -261.11% | -250.70% | -132.11% | -95.40% | -146.90% | Upgrade |
Revenue as Reported | 21.32 | 26.85 | 48.58 | 93.03 | 81.8 | 29.31 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.